A long-term, open-label trial of risperidone in children with bipolar disorder and comorbid attention-deficit/hyperactivity disorder

被引:0
|
作者
Biederman, J [1 ]
Mick, E [1 ]
Wozniak, J [1 ]
Spencer, TJ [1 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:864 / 864
页数:1
相关论文
共 50 条
  • [1] An open-label trial of reboxetine in children and adolescents with attention-deficit/hyperactivity disorder
    Tehrani-Doost, Mehdi
    Moallemi, Shirin
    Shahrivar, Zahra
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (02) : 179 - 184
  • [2] Open-label amantadine in children with attention-deficit/hyperactivity disorder
    Donfrancesco, Renato
    Calderoni, Dario
    Vitiello, Benedetto
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (05) : 657 - 663
  • [3] Comorbid attention-deficit hyperactivity disorder and bipolar disorder
    Parker, Gordon
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2023, 57 (06): : 789 - 792
  • [4] Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder:: An open clinical trial
    Tramontina, Silza
    Zeni, Cristion Patrick
    Pheula, Gabriel Ferreira
    de Souza, Carla Ketzer
    Rohde, Luis Augusto
    CNS SPECTRUMS, 2007, 12 (10) : 758 - 762
  • [5] A Long-Term Open-Label Safety and Effectiveness Trial of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder
    Findling, Robert L.
    Cutler, Andrew J.
    Saylor, Keith
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Childress, Ann C.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2013, 23 (01) : 11 - 21
  • [6] Long-Term, Open-Label, Safety Study of Edivoxetine Monotherapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Nery, Emel Serap Monkul
    Bangs, Mark
    Liu, Peng
    Ahl, Jonna
    Perahia, David
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (08) : 700 - 707
  • [7] An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder
    Shang, Chi-Yung
    Pan, Yi-Lei
    Lin, Hsiang-Yuan
    Huang, Lin-Wan
    Gau, Susan Shur-Fen
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2015, 25 (07) : 566 - 573
  • [8] Effects of modafinil in children with attention-deficit/hyperactivity disorder: An open-label study
    Rugino, TA
    Copley, TC
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2001, 40 (02): : 230 - 235
  • [9] Long-Term Treatment with Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms in Children and Adolescents with Autism Spectrum Disorder: An Open-Label Extension Study
    Harfterkamp, Myriam
    Buitelaar, Jan K.
    Minderaa, Ruud B.
    van de Loo-Neus, Gigi
    van der Gaag, Rutger-Jan
    Hoekstra, Pieter J.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2013, 23 (03) : 194 - 199
  • [10] A prospective open-label long-term treatment trial of risperidone monotherapy in children and adolescents with bipolar disorder
    Biederman, J
    Mick, E
    Wozniak, J
    Harpold, T
    Aleardi, M
    Dougherty, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S602 - S603